Table 1

Demographics, clinical characteristics, and treatment details of the TRACK Registry

0–6 Hours (N=559)6–16 Hours (N=248)16–24 Hours (N=20)>24 Hours (N=3)P values
Demographics
Age (years), mean±SD
Median (IQR)
67.4±14.9
70 (57–79)
66.1±14.6
68 (55–78)
69.9±14
73 (57–79)
80.3±14.2
87 (64–90)
0.2
Female sex, n (%)277/559 (40.6%)121/248 (48.8%)15/19 (78.9%)2/3 (66.7%)0.14
Age >80 years, n (%)122/559 (21.8%)46/248 (18.5%)4/20 (20%)2/3 (66.7%)0.18
Race, white, n (%)391/557 (70.2%)174/245 (71.0%)15/19 (78.9%)3/3 (100%)0.14
Hypertension, n (%)427/557 (76.7%)185/248 (74.6%)13/20 (65%)3/3 (100%)0.45
Atrial fibrillation, n (%)246/557 (44.2%)96/248 (38.7%)10/20 (50%)1/3 (33.3%)0.45
Diabetes mellitus, n (%)139/558 (24.9%)84/248 (33.9%)10/20 (50%)00.03
Hyperlipidemia, n (%)287/558 (51.4%)120/248 (48.4%)5/20 (25%)3/3 (100%)0.22
Any history of smoking, n (%)133/544 (24.4%)76/247 (30.8%)5/20 (25%)00.16
Coronary artery disease, n (%)156/481 (32.4%)57/219 (26%)6/15 (40%)1/3 (33.3%)0.32
Clinical data
 Admission systolic BP (mm Hg), mean±SD, median (IQR)144.3±26.3
144 (125–160)
145±27
141 (127–163)
145.7±32.5
143 (127–159.3)
146±29.6
143 (118–177)
0.98
 Admission diastolic BP (mm Hg), mean±SD, median (IQR)77.6±18.7
78 (66–87)
79.2±18.9
78 (69–90)
79.2±19.6
80.5 (62.5–94)
81.7±9.3
79 (74–92)
0.7
 Intravenous tPA use, n (%)341/557 (61.2%)78/248 (31.5%)00<0.0001
Baseline NIHSS score, mean±SD
Median (IQR)
17.9±5.9)
18 (15–21)
16.4±5.9
16 (13–20)
16.4±5.7
16 (12–20)
18±3
18 (14–22)
0.007
Occlusion site
 MCA M1/M2, n (%)295/556 (53.1%)144/247 (58.3%)12/20 (60%)1/3 (33.3%)
 MCA M3, n (%)128/556(23%)56/247 (22.7%)5/20 (25%)2/3 (66.7%)
 ACA, n (%)3/556 (0.5%)02/20 (10%)0
 ICA (cervical/intracranial), n (%)130/556 (23.4%)47/247 (19%)1/20 (5%)0
  • ACA, anterior cerebral artery; BP, blood pressure; ICA, internal carotid artery; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; tPA, tissue plasminogen activator.